As innovation accelerates, life sciences companies must align patent strategy with long-term growth. This update explores how portfolio design, operational structure, and early IP decisions shape flexibility, commercialization, and long-term value.

Once you understand patent terms and regulatory exclusivity, the next step is designing a protection timeline for your product. This article shows how to combine US and EU rules, the EU Pharma Package, and development choices into a practical exclusivity map for your asset.